secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001437749-23-029034
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q3 sales $39.5M (+18.8% YoY); operating income $2.1M vs loss
----------------------------------------------------------------------

- GAAP net income $1.3M ($0.08 diluted EPS) vs net loss of $0.2M a year ago.
- Adjusted EPS $0.10 vs adjusted loss of $0.03 in Q3 2022.
- Gross margin improved 460 bps to 24.8% on price realization and level-loaded production.
- Government/defense sales up 48.1%; commercial sales up 5.6%.
- Backlog $101.1M at quarter-end, with over $35M expected to ship in remaining 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774923029034/0001437749-23-029034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774923029034/ulbi20231025_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-029034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer